NMPA Approval

Compound Paracetamol and Amantadine Hydrochloride Capsules

Approval Number

国药准字H33020318

Company浙江迪耳药业有限公司

Registration Date

May 8, 2020

Drug Information

Generic Name

复方氨酚烷胺胶囊

Brand Name

金叶

Dosage Form

胶囊剂

Strength

复方

Drug Type

化学药品

Registration Date

May 8, 2020

Company Information

Applicant Company

Company Name浙江迪耳药业有限公司

Manufacturing Company

Company Name浙江迪耳药业有限公司

Company Address

浙江省金华市金衢路128号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.